GeneAdviser

About:

Our mission is to make genetic testing for rare diseases more accessible to clinicians around the world.

Website: http://www.geneadviser.co.uk/

Twitter/X: geneadviser

Top Investors: Jonathan Milner

Description:

Genetics is advancing at a rapid pace, transforming research and revolutionizing the way we diagnose and treat complex diseases such as heart disease and cancer. GeneAdviser is a team of scientists and developers specialized in genetics and bioinformatics, determined to increase access to genomic medicine in the clinic. GeneAdviser develops innovative solutions to make genomic medicine more accessible, partnering with a portfolio of private and public laboratories in the UK and overseas. GeneAdviser's approach is strongly shaped by our scientific background and experience. GeneAdviser's flexible, powerful online ordering platform for genetic tests enables clinicians to find and order tests for all medical specialties. GeneAdviser's clinical grade tests are from accredited laboratories that consistently deliver high-quality diagnostics, enabling healthcare professionals to provide their patients with better care.

Total Funding Amount:

350000 GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2014-01-01

Contact Email:

info(AT)geneadviser.com

Founders:

Jelena Aleksic, Robert Stojnic

Number of Employees:

1-10

Last Funding Date:

2016-06-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai